Regulation of phosphoenolpyruvate carboxykinase and fatty acid synthetase in brown fat of suckling rats.
Infant rats were injected with prednisolone (0.5-5 mg/100 g wt). This caused phosphoenolpyruvate carboxykinase (PEPCK) activity to rise in liver and to decrease in brown fat. Fatty acid synthetase (FAS) activity remained unchanged in liver but increased in brown fat. A single injection of prednisolone caused hepatic PEPCK activity to remain elevated for at least 7 days. Brown fat FAS also remained high for that period. However, brown fat PEPK activity returned to normal on the third day after the injection. A single injection of prednisolone or cortisone to 5-day-old rats caused a transient elevation of the blood level of insulin and a prolonged decrease in that of growth hormone. No effect on the level of glucagon was noted. Injections of insulin had effects similar to those of prednisolone, i.e. a rise in hepatic and a fall in brown fat PEPCK. Using antibodies prepared to hepatic PEPCK it was shown that the observed changes were due to changes in the rate of synthesis of the enzyme. Using actinomycin D indirect evidence was obtained that changes in FAS activity of brown fat were also due to changes in the synthetic rate.
D002001:Adipose Tissue, Brown / Q000201:enzymology*; D000818:Animals; D000833:Animals, Suckling; D003348:Cortisone / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D064429:Fatty Acid Synthases / Q000378:metabolism*; D005934:Glucagon / Q000097:blood; D013006:Growth Hormone / Q000097:blood; D007328:Insulin / Q000097:blood / Q000494:pharmacology; D010729:Phosphoenolpyruvate Carboxykinase (GTP) / Q000276:immunology / Q000378:metabolism*; D011239:Prednisolone / Q000494:pharmacology; D051381:Rats
D007328:Insulin; D003609:Dactinomycin; D013006:Growth Hormone; D005934:Glucagon; D011239:Prednisolone; D064429:Fatty Acid Synthases; D010729:Phosphoenolpyruvate Carboxykinase (GTP); D003348:Cortisone